These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 28930757)
1. High Expression of CCR7 Predicts Lymph Node Metastasis and Good Prognosis in Triple Negative Breast Cancer. Li X; Sun S; Li N; Gao J; Yu J; Zhao J; Li M; Zhao Z Cell Physiol Biochem; 2017; 43(2):531-539. PubMed ID: 28930757 [TBL] [Abstract][Full Text] [Related]
2. Phosphorylated eIF2α predicts disease-free survival in triple-negative breast cancer patients. Guo L; Chi Y; Xue J; Ma L; Shao Z; Wu J Sci Rep; 2017 Mar; 7():44674. PubMed ID: 28294178 [TBL] [Abstract][Full Text] [Related]
4. Novel genes associated with lymph node metastasis in triple negative breast cancer. Mathe A; Wong-Brown M; Morten B; Forbes JF; Braye SG; Avery-Kiejda KA; Scott RJ Sci Rep; 2015 Nov; 5():15832. PubMed ID: 26537449 [TBL] [Abstract][Full Text] [Related]
5. Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer. Kodama J; Hasengaowa ; Kusumoto T; Seki N; Matsuo T; Ojima Y; Nakamura K; Hongo A; Hiramatsu Y Ann Oncol; 2007 Jan; 18(1):70-76. PubMed ID: 17032700 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Takanami I Int J Cancer; 2003 Jun; 105(2):186-9. PubMed ID: 12673677 [TBL] [Abstract][Full Text] [Related]
7. CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Arigami T; Natsugoe S; Uenosono Y; Yanagita S; Arima H; Hirata M; Ishigami S; Aikou T Int J Oncol; 2009 Jul; 35(1):19-24. PubMed ID: 19513547 [TBL] [Abstract][Full Text] [Related]
8. Differential roles of Bcl2L12 and its short variant in breast cancer lymph node metastasis. Chien ST; Yang TF; Yang MC; Hsu CM; Hong YR; Lee TM Oncol Rep; 2015 Aug; 34(2):961-71. PubMed ID: 26082034 [TBL] [Abstract][Full Text] [Related]
9. Elevated expression of HABP1 is a novel prognostic indicator in triple-negative breast cancers. Wang J; Song Y; Liu T; Shi Q; Zhong Z; Wei W; Huang S; Pang D Tumour Biol; 2015 Jun; 36(6):4793-9. PubMed ID: 25794640 [TBL] [Abstract][Full Text] [Related]
10. Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer. Chung SY; Jung YY; Park IA; Kim H; Chung YR; Kim JY; Park SY; Im SA; Lee KH; Moon HG; Noh DY; Han W; Lee C; Kim TY; Ryu HS Clin Exp Metastasis; 2016 Feb; 33(2):179-85. PubMed ID: 26585892 [TBL] [Abstract][Full Text] [Related]
11. Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options. Gasparini P; Fassan M; Cascione L; Guler G; Balci S; Irkkan C; Paisie C; Lovat F; Morrison C; Zhang J; Scarpa A; Croce CM; Shapiro CL; Huebner K PLoS One; 2014; 9(2):e88525. PubMed ID: 24505496 [TBL] [Abstract][Full Text] [Related]
12. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer. Ma F; Ding X; Fan Y; Ying J; Zheng S; Lu N; Xu B PLoS One; 2014; 9(11):e112765. PubMed ID: 25393310 [TBL] [Abstract][Full Text] [Related]
13. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Cabioglu N; Yazici MS; Arun B; Broglio KR; Hortobagyi GN; Price JE; Sahin A Clin Cancer Res; 2005 Aug; 11(16):5686-93. PubMed ID: 16115904 [TBL] [Abstract][Full Text] [Related]
14. CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis. Wu J; Li L; Liu J; Wang Y; Wang Z; Wang Y; Liu W; Zhou Z; Chen C; Liu R; Yang R Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):835-842. PubMed ID: 30032244 [TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients. Urru SAM; Gallus S; Bosetti C; Moi T; Medda R; Sollai E; Murgia A; Sanges F; Pira G; Manca A; Palmas D; Floris M; Asunis AM; Atzori F; Carru C; D'Incalci M; Ghiani M; Marras V; Onnis D; Santona MC; Sarobba G; Valle E; Canu L; Cossu S; Bulfone A; Rocca PC; De Miglio MR; Orrù S BMC Cancer; 2018 Jan; 18(1):56. PubMed ID: 29310602 [TBL] [Abstract][Full Text] [Related]
16. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis. Liu Y; Ji R; Li J; Gu Q; Zhao X; Sun T; Wang J; Li J; Du Q; Sun B J Exp Clin Cancer Res; 2010 Feb; 29(1):16. PubMed ID: 20181250 [TBL] [Abstract][Full Text] [Related]
17. Use of NRP1, a novel biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict lymph node metastasis in squamous cell carcinoma of the tongue. Al-Shareef H; Hiraoka SI; Tanaka N; Shogen Y; Lee AD; Bakhshishayan S; Kogo M Oncol Rep; 2016 Nov; 36(5):2444-2454. PubMed ID: 27666723 [TBL] [Abstract][Full Text] [Related]
18. CCR7 expression and intratumoral FOXP3+ regulatory T cells are correlated with overall survival and lymph node metastasis in gastric cancer. Zhou S; Shen Z; Wang Y; Ma H; Xu S; Qin J; Chen L; Tao H; Zhen Z; Chen G; Zhang Z; Li R; Xiao H; Zhong C; Yang Y; Liang C PLoS One; 2013; 8(9):e74430. PubMed ID: 24040244 [TBL] [Abstract][Full Text] [Related]